Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs

Stroke

Volumn 34, Issue 7, 2003, Pages 1667-1672

  Cantu, Carlos ^a   Arauz, Antonio ^b   Murillo Bonilla, Luis M ^b   López, Mario ^b   Barinagarrementeria, Fernando ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b NONE

Author keywords

Phenylpropanolamine; Stroke; Sympathomimetics

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; NON PRESCRIPTION DRUG; OXYMETAZOLINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN VASCULITIS; BRAIN VASOSPASM; COMMON COLD; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; STROKE; SUBARACHNOID HEMORRHAGE;

ADOLESCENT; ADULT; AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CAUSALITY; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, NON-PRESCRIPTION; EPHEDRINE; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; OXYMETAZOLINE; PHENYLPROPANOLAMINE; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; SUBARACHNOID HEMORRHAGE; SYMPATHOMIMETICS;

EID: 0038109711     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000075293.45936.FA     Document Type: Article

References (48)

1. Ephedrine HCI. In: Compendium of Pharmaceuticals and Specialties. 36th ed. Ottawa, Canada: Canadian Pharmacists Association; 2001.
2. Fallis RJ, Fisher M. Cerebral vasculitis and hemorrhage associated with phenylpropanolamine. Neurology. 1985;35:405-408.
3. Kikta DG, Devereaux MX, Chandar K. Intracranial hemorrhages due to phenylpropanolamine. Stroke. 1985;16:510-513.
4. Stoessl AJ, Young GB, Feasby TE. Intracerebral hemorrhage and angiographic beading following ingestion of catecholaminergics. Stroke. 1985;16:734-737.
5. Lake CR, Gallant S, Masson E, Miller P. Adverse drug effects attributed to phenylpropanolamine: a review of 142 cases reports. Am J Med. 1990;89:195-208.
6. Barinagarrementeria F, Méndez A, Vega F. Hemorragia cerebral asociada al uso de fenilpropanolamina. Neurología. 1990;5:292-294.
7. Johnson DA, Etters HS, Reeves DM. Stroke and phenylpropanolamine use. Lancet. 1983;56:970-973.
8. McDowell JR, Le Blanc HJ. Phenylpropanolamine and cerebral hemorrhage. West J Med. 1985;35:405-407.
9. Traynelis VC, Brick JF. Phenylpropanolamine and vasospasm. Neurology. 1986;36:593-595.
10. Maher LM. Postpartum intracranial hemorrhage and phenylpropanolamine use. Neurology. 1987;37:1686-1688.
11. From the Centers for Disease Control and Prevention. Adverse events associated with ephedrine-containing products: Texas, December 1993-September 1995. JAMA. 1996;276:1711-1712.
12. Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a Mahuang-containing drink. J Clin Psychopharmacol. 1997;17:437-439.
13. Josefson D. Herbal stimulant causes US deaths. BMJ. 1996;312:1378-1379.
14. Zahn KA, Li RL, Purssell RA. Cardiovascular toxicity after ingestion of herbal ecstasy. J Emerg Med. 1999;17:289-291.
15. Zaacks SM, Klein L, Tan CD, Rodriguez ER, Leikin JB. Hypersensitivity myocarditis associated with ephedra use. J Toxicol Clin Toxicol. 1999;37:485-489.
16. Vahedi K, Domigo V, Amarenco R, Bousser MG. Ischemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building. J Neurol Neurosurg Psychiatry. 2000;68:112-113.
17. King J. Hypertension and cerebral hemorrhage after trimolets ingestion. Med J Aust. 1979;2:258.
18. Morgan JP. Phenylpropanolamine: A Critical Analysis of Reported Adverse Reactions and Overdosage. Fort Lee, NJ: Jack K Burgess; 1986:105.
19. Forman HP, Levin S, Stewart B, Patel M, Feinstein S. Cerebral vasculitis and hemorrhage in an adolescent taking diet pills containing phenylpropanolamine: case report and review of literature. Pediatrics. 1989;83:737-741.
20. Chung Y-T, Hung D-Z, Hsu C-P, Yang D-Y, Wu T-C. Intracerebral hemorrhage in a young woman with arteriovenous malformation after taking diet control pills containing phenylpropanolamine: a case report. Chung Hua I Hsueh Tsa Chih (Taipei). 1998;61:432-435.
21. Keman W, Viscoli C, Brass L, Broderick J, Brott T, Feldmann E, Morgenstern L. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826-1832.
22. van Swieten JC, Koudastaal PJ, Viseer MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-607.
23. Barinagarrementeria F, Figuero T, Huebe J, Cantú C. Cerebral Infarction in people under 40 years: etiologic analysis of 300 cases. Cerebrovasc Dis. 1996;6:75-79.
24. Ruiz-Sandoval JL, Cantú C, Barinagarrementeria F. Cerebral hemorrhage in young people: analysis of 200 cases. Stroke. 1999;30:537-541.
25. Harrison WM, McGrath PJ, Steward JW, Quitkin F. MAOIs and hypertensive crises: the role of OTC drugs. J Clin Psychiatry. 1989;50:64-65.
26. Maertens P, Lum G, Williams JP, White J. Intracranial hemorrhage and cerebral angiopathic changes in a suicidal phenylpropanolamine poisoning. South Med J. 1987;80:1584-1586.
27. Kizer KW. Intracranial hemorrhage associated with overdose of decongestant containing phenylpropanolamine. Am J Emerg Med. 1984;2:180-181.
28. Rumack BH, Anderson RJ, Wolfe R, Fletcher EC, Vestal BK. Omade and anticholinergic toxicity: hypertension, hallucinations, and arrhythmias. Clin Toxicol. 1974;7:573-581.
29. Rumbaugh CL, Fang HC, Higgins RE, Bergeron RT, Segall HD, Teal JS. Cerebral microvascular injury in experimental drug abuse. Invest Radiol. 1976;11:282-294.
30. Mesnard B, Ginn DR. Excessive phenylpropanolamine ingestion followed by subarachnoid hemorrhage. South Med J. 1984;77:939.
31. Deocampo PD. Convulsive seizures due to phenylpropanolamine. J Med Soc N J. 1979;76:591-592.
32. Edwars M, Russo L, Harwood-Nuss A. Cerebral infarction with a single oral dose of phenylpropanolamine. Am J Emerg Med. 1987;5:163-164.
33. Sloan MA, Kittner SJ, Rigamonti D, Price TR. Occurrence of stroke associated with use/abuse of drugs. Neurology. 1991;41:1358-1364.
34. Hamilton RS, Sharieff G. Phenylpropanolamine-associated intracranial hemorrhage in an infant. Am J Emerg Med. 2000;18:343-345.
35. Tapia J. Cerebral hemorrhage associated with the use of phenylpropanolamine: clinical cases. Rev Med Chi. 1996;124:1499-1503.
36. Kase CS, Foster TE, Reed JE. Intracerebral hemorrhage and phenylpropanolamine use. Neurology. 1987;37:399-402.
37. Glick R, Hoying J, Cerullo L. Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage: case report and review. Neurosurgery. 1987;20:969-972.
38. Mueller SM. Phenylpropanolamine: a non-prescription drug with fatal side effects. N Engl J Med. 1983;308:653. Letter.
39. Bernstein E, Diskant BM. Phenylpropanolamine: a potentially hazardous drug. Ann Emerg Med. 1982;11:311-313.
40. Jick H, Aselton P, Hunter JR. Phenylpropanolamine and cerebral haemorrhage. Lancet. 1984;1071:345-348.
41. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838.
42. Loizou LA, Hamilton JG, Tsementzis SA. Intracranial hemorrhage in association with pseudoephedrine overdose. J Neurol Neurosurg Psychiatry. 1982;45:471-475.
43. Mourand I, Ducrocq X, Lacour JC, Taillandier L, Anxionnat R, Weber M. Acute reversible cerebral arteritis associated with parenteral ephedrine use. Cerebrovasc Dis. 1999;9:355-357.
44. Wen PY, Feske SK, Teoh SK, Steig PE. Cerebral hemorrhage in a patient taking fenflummine and phentermine for obesity. Neurology. 1997;49:632-633.
45. Kokkinos J, Levine SR. Possible association of ischemic stroke with phentermine. Stroke. 1993;24:310-313.
46. Montalban J, Ibáñez L, Rodríguez C, Lopez M, Sumalla J, Codina A. Cerebral infarction after excessive use of nasal decongestants. J Neurol Neurosurg Psychiatry. 1989;52:541-543.
47. Magargal LE, Sanbom GE, Donoso LA, Gonder JR. Branch retinal artery occlusion after excessive use of nasal spray. Ann Ophthalmol. 1985;17:500-501.
48. Dowd J, Bailey D, Moussa K, Nair S, Doyle R, Culpepper-Morgan JA. Ischemic colitis associated with pseudoephedrine: four cases. Am J Gastroenterol. 1999;94:2430-2434.